Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats

scientific article published in November 2001

Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DIABETES.50.11.2591
P698PubMed publication ID11679439
P5875ResearchGate publication ID11674324

P2093author name stringRomijn JA
Burger HJ
Herling AW
Meijer AJ
Kuipers F
Reijngoud DJ
Wiegman CH
Bandsma RH
ter Harmsel A
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectsteatosisQ1365091
P304page(s)2591-2597
P577publication date2001-11-01
P1433published inDiabetesQ895262
P1476titleAcute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats
P478volume50

Reverse relations

cites work (P2860)
Q35630807A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism
Q46427847Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production
Q64377408Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice
Q96948590An early-life diet containing large phospholipid-coated lipid globules programs later-life postabsorptive lipid trafficking in high-fat diet but not in low-fat dietfed mice
Q36941874Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice
Q45558516Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1
Q42506602Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance
Q46835749Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis
Q48274557Flux analysis of inborn errors of metabolism.
Q41979207Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis
Q38303475HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation
Q38160330Hepatic glucose sensing and integrative pathways in the liver
Q33474784High fat feeding induces hepatic fatty acid elongation in mice
Q86692314In vivo anti-diabetic potential of chlorogenic acid as a consequence of synergism with other phenolic compounds?
Q46562134Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.
Q40446912Intestinal glucose-dependent expression of glucose-6-phosphatase: involvement of the aryl receptor nuclear translocator transcription factor.
Q37162701Liver lipid metabolism
Q34682304New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c
Q30654400Noninvasive measurement of murine hepatic acetyl-CoA ¹³C-enrichment following overnight feeding with ¹³C-enriched fructose and glucose
Q38128788Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes
Q26820876Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux
Q34654019Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease
Q38925481Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Q37014973Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance
Q55032191The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.
Q26865636The SLC37 family of sugar-phosphate/phosphate exchangers
Q41986400The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression
Q33409336Transcriptome analysis of a spontaneous mutant in sweet orange [Citrus sinensis (L.) Osbeck] during fruit development

Search more.